Crossing the Chasm: Marketing and Selling Disruptive Products to Mainstream Customers

by Geoffrey A. Moore

In a year Documentum had demonstrated that it could solve this problem, and some thirty of the top forty pharmaceutical companies had committed to its solution. That is what drove its sales to $8 million and then to $25 million.